Your browser doesn't support javascript.
loading
Photobiomodulation Therapy for Multiple Painful Fixed Drug Eruptions: The First Case Report.
Palma, Luiz Felipe; Campos, Luana; de Oliveira, Sandro Francisco; Penido, Ludmila; Morimoto, Susana; de Moraes, Luís Otávio Carvalho.
Afiliação
  • Palma LF; Department of Pathology, Federal University of São Paulo, São Paulo, SP, Brazil.
  • Campos L; Graduate Program in Implantology, University of Santo Amaro, School of Dentistry, São Paulo, SP, Brazil.
  • de Oliveira SF; Graduate Dentistry Program, Ibirapuera University, São Paulo, SP, Brazil.
  • Penido L; Dermatology Center, São Camilo Hospital, São Paulo, SP, Brazil.
  • Morimoto S; School of Dentistry, Department of Orthodontics and Pediatric Dentistry, University of São Paulo, São Paulo, SP, Brazil.
  • de Moraes LOC; Department of Morphology and Genetics, Federal University of São Paulo, São Paulo, SP, Brazil.
J Lasers Med Sci ; 14: e4, 2023.
Article em En | MEDLINE | ID: mdl-37089767
ABSTRACT

Introduction:

Fixed drug eruption (FDE), a very specific adverse drug reaction and one of the most common types of drug eruption, generally resolves spontaneously within 7-10 days upon withdrawal of the causative agent; however, extensive and severe cases may also require systemic drug therapy. The present study aimed to report a case in which a broad spectrum of severe, painful lesions of FDE was managed with photobiomodulation therapy (PBMT). Case Report A 31-year-old Caucasian woman presented with many extremely painful mucocutaneous lesions of FDE which had arisen 8 days before, following a long period of hospitalization. The lesions were not responsive to either corticosteroids or analgesics within 5 days, and then seven daily sessions of PBMT were proposed. Pain alleviation was achieved on the 1st day of PBMT, and the lesions showed an advanced course of healing on the 3rd day. Within 7 days of PBMT, the lesions were almost completely repaired. In a 3-month follow-up period, no relapse of any FDE lesion was reported.

Conclusion:

PBMT may be a promising strategy for the management of painful lesions of FDE refractory to conventional medication therapy. However, further studies are needed to confirm this hypothesis.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Lasers Med Sci Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Lasers Med Sci Ano de publicação: 2023 Tipo de documento: Article